(312) 305 43 22GET APPOINTMENT
Dr. Gunaydin graduated from Antalya Yusuf Ziya Oner Science High School. He obtained his MD degree from Hacettepe University School of Medicine. Dr. Gunaydin received his PhD degree in Tumor Biology and Immunology as part of the Hacettepe University School of Medicine MD-PhD Combined Degree Program. Dr. Gunaydin carried out research studies at Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, University of Goettingen School of Medicine and Yale University School of Medicine.Dr. Gunaydin received Turkiye Kanserle Savas Vakfi Prof. Dr. Ali Haydar Taspinar Award in 2013 and European School of Oncology Fellowship Award in 2009. His main research areas are tumor immunology, tumor microenvironment, cancer immunotherapy and cancer metabolism.
· Karaman O, Almammadov T, Gedik ME, Gunaydin G, Kolemen S, Gunbas G. Mitochondria‐Targeting Selenophene‐Modified BODIPY‐Based Photosensitizers for the Treatment of Hypoxic Cancer Cells. ChemMedChem. 2019;14:1879. Cover Article.
· Gok Yavuz B, Gunaydin G, Gedik ME, Kosemehmetoglu K, Karakoc D, Ozgur F, Guc D. Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1+ TAMs. Scientific Reports. 2019;9:3172.
· Simsek Turan I, Gunaydin G, Ayan S, Akkaya EU. Molecular demultiplexer as a terminator automaton. Nature Communications. 2018;9:805.
· Simsek Turan I, Yildiz D, Turksoy A, Gunaydin G, Akkaya EU. A Bifunctional Photosensitizer for Enhanced Fractional Photodynamic Therapy: Singlet Oxygen Generation in the Presence and Absence of Light. Angewandte Chemie Int. Ed. 2016;55:2875.
· Gunaydin G, Kesikli SA, Guc D. Cancer associated fibroblasts have phenotypic and functional characteristics similar to the fibrocytes that represent a novel MDSC subset. Oncoimmunology. 2015;4(9):9.
· Dolen Y, Gunaydin G, Esendagli G, Guc D. Granulocytic subset of myeloid derived suppressor cells in rats with mammary carcinoma. Cellular Immunology. 2015;295(1):29-35.
· Gunaydin G, Dolen Y, Kesikli SA. Fibroblast-Derived CCL2 Induces Cancer Stem Cells-Letter. Cancer Research. 2013;73(2):1031.
|Foreign Experience / Education||Johns Hopkins University / Research Goettingen University / Research Yale University / Research|
|Foreign Language||İngilizce, Almanca|
: (312) 305 43 22